Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls
Environmental Research · 2026-08 · 303 · 124763
DOI: 10.1016/j.envres.2026.124763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Research, 2026-08. Verfasst von Farren B S Briggs und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: fbb31@miami.edu. Hauptthemen laut MEDLINE: Fluorocarbons, Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Environmental Pollutants. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background and Objectives. Perfluoroalkyl substances (PFAS) are persistent environmental contaminants with endocrine and neuroimmune properties, yet relevance to multiple sclerosis (MS) remains unclear. Recent European data suggested MS-PFAS associations may vary by sex. We evaluated sex-stratified and disease-specific PFAS-MS associations in U.S. cohorts and explored endocrine and transcriptomic correlates.
Methods
Liquid chromatography–mass spectrometry-derived serum PFHxS, PFOA, and PFOS were quantified in 439 participants (226 MS, 106 healthy controls [HC], 59 neuromyelitis optica spectrum disorder [NMOSD], 48 myelin oligodendrocyte glycoprotein antibody-associated disease [MOGAD]) across two U.S. cohorts. PFAS levels were compared across diagnostic groups with sex stratification. Exposure-risk models estimated MS odds. Among MS-HC females, associations between PFAS and sex-steroid metabolites were evaluated, and PFAS-correlated gene-expression signatures were examined in a subset of MS females.
Results
PFHxS was consistently elevated in MS females compared with HC, NMOSD, and MOGAD females, while PFOA showed a similar but less uniform pattern; male associations were imprecise. Exposure-risk models demonstrated dose-response and non-linear associations for PFHxS, with directionally similar patterns for PFOA; PFHxS was the primary contributor in mixture analyses. PFOS associations were weaker and less consistent. Exploratory analyses observed significant MS×PFOA interactions for several steroid metabolites, and PFAS-correlated genes showed tentative enrichment of neuronal membrane pathways.
Conclusions
Across two U.S. cohorts, PFHxS demonstrated consistent association with MS, particularly among females, while PFOA showed a similar but less uniform pattern. Exploratory findings suggest plausible pathways linking PFAS exposure to MS. Multi-ethnic and longitudinal studies are needed to expand generalizability and clarify temporality and causality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. Electronic address: fbb31@miami.edu.
- Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
- Decode Health, Inc., Department of Medicine, Vanderbilt University School of Medicine, Thomas F. Frist, Jr. College of Medicine, Belmont University, Nashville, TN, USA; New York University, New York, NY, USA.
- University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Pharmacology and Toxicology, East Carolina University, Greenville, NC, USA.
- Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Förderung
- NINDS NIH HHS
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Briggs, F. B. S., Montini, F., Spurlock, C. F., Ryan, C., Cooke Bailey, J. N., Trapl, E. S., Shaginurova, G. I., Wylezinski, L. S., Sesler, C. L., Esfahani, M. F., Sagen, J., Gardener, H. E., McCauley, J. L., Caban-Martinez, A. J., Brambilla, R., Amezcua, L., & Tobin, W. O. (2026). Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls. Environmental Research, 303, 124763. https://doi.org/10.1016/j.envres.2026.124763
Vancouver
Briggs FBS, Montini F, Spurlock CF, Ryan C, Cooke Bailey JN, Trapl ES, et al. Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls. Environmental Research. 2026;303:124763. doi:10.1016/j.envres.2026.124763
BibTeX
@article{Briggs2026,
author = {Briggs, Farren B S and Montini, Federico and Spurlock, Charles F and Ryan, Christine and Cooke Bailey, Jessica N and Trapl, Erika S and Shaginurova, Guzel I and Wylezinski, Lukasz S and Sesler, Cheryl L and Esfahani, Mahboobeh Fereidan and Sagen, Jessica and Gardener, Hannah E and McCauley, Jacob L and Caban-Martinez, Alberto J and Brambilla, Roberta and Amezcua, Lilyana and Tobin, W Oliver},
title = {Associations between perfluoroalkyl substances and multiple sclerosis in U.S. cohorts compared with NMOSD, MOGAD, and healthy controls},
journal = {Environmental Research},
year = {2026},
volume = {303},
pages = {124763},
doi = {10.1016/j.envres.2026.124763}
}
EUVIMED